{
"@context": "/terms/",
"@id": "/treatments/bd6041e7-2309-46de-b82f-66583e3356f9/",
"@type": [
"Treatment",
"Item"
],
"aliases": [
"pankbase-consortium:treatment_Artemether"
],
"amount": 10,
"amount_units": "μM",
"audit": {
"INTERNAL_ACTION": [
{
"category": "mismatched status",
"detail": "Released treatment [bd6041e7-2309-46de-b82f-66583e3356f9](/treatments/bd6041e7-2309-46de-b82f-66583e3356f9/) has deleted subobject award [U24DK13851](/awards/U24DK13851/).",
"level": 30,
"level_name": "INTERNAL_ACTION",
"name": "audit_item_status",
"path": "/treatments/bd6041e7-2309-46de-b82f-66583e3356f9/"
}
]
},
"award": {
"@id": "/awards/U24DK13851/",
"component": "data coordination"
},
"biosamples_treated": [],
"creation_timestamp": "2025-01-07T18:56:01.540414+00:00",
"depletion": false,
"description": "An artemisinin derivative that is artemisinin in which the lactone has been converted to the corresponding lactol methyl ether. It is used in combination with lumefantrine as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.",
"lab": {
"@id": "/labs/pankbase-consortium/",
"title": "Pankbase Consortium, PanKbase"
},
"notes": "From study GSE142465",
"purpose": "stimulation",
"release_timestamp": "2025-01-10T09:35:13.651558+00:00",
"schema_version": "7",
"status": "released",
"submitted_by": {
"@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
"title": "Ying Sun"
},
"submitter_comment": "https://genomebiology.biomedcentral.com/articles/10.1186/s13059-020-02006-2#Sec10",
"summary": "Treatment of 10 μM Artemether",
"treatment_term_id": "CHEBI:195280",
"treatment_term_name": "Artemether",
"treatment_type": "chemical",
"uuid": "bd6041e7-2309-46de-b82f-66583e3356f9"
}